Transcervical fibroid ablation (TFA) to treat symptomatic uterine fibroids (UFs) is effective for a wide range of fibroid types and sizes, according to preliminary results of the first 160 women treated in the Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE registry).
Expanding coverage for noninvasive prenatal testing (NIPT) through a performance-based, risk-sharing agreement (PBRSA) resulted in a significant increase in NIPT use, a significant decrease in conventional prenatal screening methods, and a negligible increase in per member per month (PMPM) cost at Harvard Pilgrim Health Care (HPHC) in New England.
The CDC and FDA will further investigate the reports of blood clots following administration of the vaccine.
A literature review has found that the prevalence thresholds of various screening tests used in ob/gyn health care settings are significantly higher than the estimated disease prevalence.
Overactive bladder affects a significant portion of the overall population and has substantial impact on daily activities and quality of life.
This case illustrates how a clear explanation and empathy for the patient’s concerns may have avoided litigation altogether.
A higher risk of adult-onset heart failure was found in this Swedish study that investigated its association with singleton live births before 37 weeks gestation.
A team of investigators has found that women with Down Syndrome received gynecologic care at lower-than-recommended rates and at substantially lower rates than other forms of health care. The investigators have called for efforts to improve gynecologic care for this vulnerable population.
What to look for this week on Contemporary OB/GYN®
Curbside Consults delivers expert perspectives from physicians outside of the OB/GYN specialty to provide insight into various health issues affecting pregnant women. This new section is the brainchild of Editorial Advisory Board member Christine Isaacs, MD.
It was a very busy week for the Contemporary OB/GYN® team.
Treating COVID-19 in pregnant patients brings extra challenges, risks.
Rarely a day goes by without a post, article, or email about physician burnout.
A young general practitioner in New York was on the front lines of an epidemic that was as mysterious in its pathology as coronavirus disease 2019 (COVID-19). Some patients would develop only mild symptoms, but others would get the worst of it, ultimately succumbing to the disease, as medical professionals and other scientists rushed to understand how the disease was being spread.
Lower levels of testing and higher positivity rates, higher rates of dangerous drug combination use, and increases in fatal and non-fatal overdoses during the coronavirus disease 2019 (COVID-19) pandemic reveal a need for more resources to address the opioid epidemic in the United States.
Introducing Contemporary OB/GYN®'s Deputy Editor, Jon I. Einarsson, MD, MPH, PhD.
This video interview features Rachael Phelps, MD, Medical Director at Planned Parenthood of Central and Western New York, and of the Rochester LARC Initiative; and Amber Truehart, MD, Assistant Professor of Obstetrics and Gynecology, Section of Family Planning and Contraceptive Research at the University of Chicago.
A prospective study to assess the effects of an oral contraceptive containing estetrol and drospirenone on ovarian function found treatment achieved complete ovulation inhibition.
A prospective observational study found that hormone therapy resulted in a significant reduction in nocturia prevalence and bother in postmenopausal women with two nocturnal voids.
The pandemic has forced us to get more creative in managing patients’ needs, especially when it comes to contraception
A study has found that caffeine consumption during pregnancy, even in amounts less than the recommended 200 mg per day, is linked to smaller neonatal anthropometric measurements.
As there is a higher rate of uterine fibroids among Black women, researchers seek to find the cause.
The diagnosis and treatment of diaphragmatic endometriosis (DE) is often delayed, due to lack of awareness by patients and healthcare professionals alike, according to an international patient survey.
What to look for this week on Contemporary OB/GYN®
Since pregnant and lactating women were excluded in the initial trials for coronavirus disease 2019 (COVID-19) vaccines, a team of researchers now has released study results that show the Moderna and Pfizer vaccines are indeed safe and effective for this population. It is the first data to substantiate the use of mRNA vaccines in pregnancy.
It's been a very busy week for the Contemporary OB/GYN team.
Missing just 1 screening can lead to significant increase in risk, investigators say.
In this episode, Dr. Rachel Phelps of the Rochester LARC Initiative sits down with Dr. Amber Trueheart of the University of Chicago Department of Obstetrics and Gynecology.
Panel will be focused on early detection, screening, and treatment of ovarian cancer.
Women who have onset of type 1 diabetes (T1D) before menarche have a significantly shorter reproductive life compared to women who have never had diabetes, according to a study in the journal Menopause.
